Fed. Circ. Backs Actavis' $12M Patent Suit Cost Deduction
By Anna Scott Farrell · March 21, 2025, 12:11 PM EDT
Drugmaker Actavis can take a $12 million tax deduction for money it spent fending off lawsuits while securing approval to sell generic birth control and other drugs, the Federal Circuit ruled...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login